Clinical Trial Update: Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing anlotinib hydrochloride to imatinib mesylate in locally advanced, unresectable, or metastatic chordoma; current status is unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma

Drugs mentioned

• Anlotinib hydrochloride (anlotinib)
• Imatinib mesylate (Imatinib)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Effect of Drugs, Quality of Life | Phase 2 | Status: UNKNOWN